RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Overview Fund Activity
Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

46 hedge funds and large institutions have $50.5M invested in RVL Pharmaceuticals plc Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+8
Holders Change %
+21.05%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
8
Reduced
8
Closed
7
Calls
$441K
Puts
$133K
Net Calls
+$308K
Net Calls Change
+$225K

Top Buyers

1
ACM
1
Athyrium Capital Management
New York
$30.7M
2
ACM
2
AIGH Capital Management
Maryland
$1.55M
3
UOC
3
UBS O'Connor
Illinois
$580K
4
WVP
4
Worth Venture Partners
New Jersey
$390K
5
Millennium Management
5
Millennium Management
New York
$341K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.62M
2
Morgan Stanley
2
Morgan Stanley
New York
$2.46M
3
TC
3
Titleist Capital
Texas
$206K
4
Charles Schwab
4
Charles Schwab
California
$28K
5
Prudential Financial
5
Prudential Financial
New Jersey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PNC Financial Services Group
51
PNC Financial Services Group
Pennsylvania
– -$1K -700 Closed
1 2
3